Status:

COMPLETED

Study of Early Enteral Dextrose in Sepsis

Lead Sponsor:

University of Pittsburgh

Collaborating Sponsors:

National Institutes of Health (NIH)

National Institute of General Medical Sciences (NIGMS)

Conditions:

Sepsis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study is a prospective single-center randomized double-blinded placebo-controlled clinical trial testing the effects of early enteral dextrose as a therapeutic agent in critically ill patients wi...

Detailed Description

The central objective of this research project is to determine how early caloric support impacts inflammatory and metabolic outcomes in the acute phase of sepsis. Preliminary data from our mouse model...

Eligibility Criteria

Inclusion

  • New presentation of sepsis characterized by a confirmed or suspected infection, with an acute increase from baseline in a modified Sepsis-Related Organ Failure Assessment (SOFA) score of greater than or equal to 2 points. If baseline values are unknown, baseline SOFA score of 0 will be assumed.
  • Available enteral access defined by: (1) an existing nasogastric or orogastric tube, (2) plans to place a nasogastric or orogastric tube, or (3) an existing percutaneous endoscopic gastrostomy (PEG) tube.
  • Less than 48 hours since meeting criteria for sepsis.
  • Expected to stay at least 24 hours in the ICU.

Exclusion

  • Pre-existing continuous enteral tube feed use prior to study entry.
  • Diabetic ketoacidosis or diabetic hyperosmolar hyperglycemic syndrome.
  • Previously enrolled in this study within the same hospital admission.
  • ICU physician request to exclude patient based on clinical assessment.

Key Trial Info

Start Date :

June 4 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2020

Estimated Enrollment :

58 Patients enrolled

Trial Details

Trial ID

NCT03454087

Start Date

June 4 2018

End Date

April 1 2020

Last Update

April 7 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States, 15237